ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

The Glivec Precedent

The Glivec Precedent
Evergreening and the issues this practice of abusive patenting raised were first highlighted in the late 1990s with the HIV epidemic, when medicines were priced way out of reach. The Supreme Court’s...
This article looks at Glivec’s journey from its invention to its patenting and sale while questioning the concept of credit for inventions in science and technology.
Despite a progressive judgment by the Supreme Court of India on Section 3(d) of the Indian Patents Act, the processes of legislation and implementation are not equipped to uphold the spirit of the...
This article looks at how inventions are assessed by various policy regimes in the world and analyses the Indian regulations in this light. A well-formulated and scientifi c legislation to apply the...
Bringing together the various aspects of and issues related to the recent Supreme Court judgment rejecting Novartis's patent for Glivec, this writeup introduces a set of articles discussing...
The Supreme Court judgment in the Novartis case is important as it vindicates the entire process leading to health safeguards being incorporated in the Indian Patents Act. The article discusses this...
A detailed account of the examination of Section 3(d) of the Indian Patents Act in the Supreme Court's judgment on Novartis's patent application for Glivec.
Back to Top